1792 Insights
The 1792 Exchange is committed to delivering sharp, data-driven analysis of corporate America’s political entanglements. Discover what investors, executives, and concerned citizens should know regarding why businesses should return to neutral, mission-focused operations.
Corporate Support for A4TE: Ideological Activism and Reputational Risk
Advocates for Trans Equality (A4TE) is a radical organization promoting transgender ideology in law and policy in the United States. Formed in 2024 through the merger of the National Center for Transgender Equality (NCTE) and the Transgender Legal Defense and Education Fund (TLDEF), A4TE engages in public policy advocacy, impact litigation, political activity, research and data collection, and community organizing to advance its objectives. A4TE has actively opposed federal and state legislation seeking to restrict transition-related medical interventions for minors. Including, organizing a coalition of more than 160 national and grassroots organizations that urged Congress to reject H.R. 3492, legislation which sought to establish federal criminal penalties for providing certain transition-related procedures to minors. A4TE characterized the targeted treatments as “safe and evidence-based” health care and argued that restrictions would interfere with medical decision-making. A4TE references WPATH’s Standards of Care in support of transition-related medical care, despite the guidelines facing federal legal scrutiny. In June 2026, the FTC and four states sued WPATH, alleging misleading claims about the safety, effectiveness, and medical necessity of certain pediatric interventions. Major corporations, including Apple, Amazon, Google, and Disney, have been identified as corporate partners of A4TE. Through these partnerships, companies may receive opportunities to …
Corporate stewardship, the cost of ideological activism, and the trust that built America.
In this episode of The WallBuilders Show, Doug Napier, Executive Chairman and CEO of 1792 Exchange, joined host Rick Green to discuss The American Company, 1792 Exchange’s new effort to define and celebrate companies that act American. The conversation explores what separates a patriotic company from one that only waves the flag, and how Americans can help recognize the companies doing it right. Key Topics Discussed:
Inspire Investing Maps the Four-Year Reversal on Gender-Transition Care for Minors
On August 11, 2026, the Centers for Medicare & Medicaid Services issued a first-of-its-kind final rule barring federal Medicaid and CHIP dollars from covering puberty blockers, cross-sex hormones, or surgeries for minors, effective October 13, 2026. A new analysis from Inspire Investing frames the rule as the capstone of a four-year reversal across American law, medicine, and corporate benefit plans. The piece, by Chris Hubbard with Tim Schwarzenberger, traces how a once-expanding consensus fractured, in the courts, in the medical literature, in Europe, and in corporate boardrooms, and why values-driven investors are now pressing companies on the issue. The Supreme Court’s June 2025 ruling in United States v. Skrmetti upheld state limits, leaving bans in roughly 27 states in force. A May 2025 HHS evidence review found the certainty of benefit “very low,” echoing England’s Cass Review. Corporate participation in the Human Rights Campaign’s Corporate Equality Index fell 65% in a single year, from 377 Fortune 500 companies to 131. 1792 Exchange has named 550-plus companies whose plans still cover these procedures for minor dependents and wrote to 568 companies in June urging them to exclude transgender drugs and surgeries for children. Inspire organized a coalition representing more than $100 …
Mount Sinai Backs Down. Will Corporate America?
The writing is on the wall for gender ideology and corporate America should respond. Its authorities are discredited, its sciences unfounded, and its public support dwindling — not to mention the very providers who push sex-denying procedures on minors are now being held accountable for the experiment they’ve been running. Mount Sinai Health System is the latest example of this as they reach an agreement with the Department of Justice to stop providing sex-denying procedures on minors and provide free health care to those experiencing adverse side-effects of their experimentation. DOJ began its investigation on the premise that the nonprofit hospital may have violated federal law regarding its sex-denying procedures on children. The nationwide probe follows the landmark HHS report that exposed WPATH perverse influences on providers, along with an insurance scheme that let hospitals to charge insurance, private and federally subsidized, for sex-denying procedures on minors that would typically not be covered. Additionally, Mount Sinai agreed to dedicate $2 million to treating the adverse effects of sex-denying interventions, free of charge, to those who received them as minors. Keep in mind, sex-denying interventions are largely irreversible and carry side effects into adulthood, even for those who detransition. Detranstitioner Chloe …
Starbucks and the Rising Cost of DEI
Starbucks becomes the latest example of the legal and financial liability of DEI governance policies after settling its civil rights lawsuit with the state of Florida. The settlement came with the agreement to pay the state $1 million and commit to complying with the state’s civil rights laws. The suit claimed that the company paid certain employees more than employees of other races with equal experience, and that until March 2024 the company tied executive bonuses to diversity goals. This adds to the growing list of companies spending millions of dollars to settle allegations of discriminatory hiring practices, with Accenture, Deloitte, and IBM all paying multi-million-dollar settlements to the DOJ over the last few months. The coffee giant has a long, recorded history of DEI priorities, but as part of the settlement, it has also agreed to not participate in organizations that require increased racial diversity on its board of directors. This is a clear walk-back of the company’s 2020 commitment to BIPOC representation of “at least 30% at all corporate levels and 40% at all retail and manufacturing roles by 2025,” which was tied to the Board Diversity Action Alliance. Companies like Starbucks are a cautionary tale for others …
Shareholders Challenge Nike over support for transgender surgeries on minors
At Nike’s annual shareholder meeting this month, Christian and conservative investors put the company’s relationship with the Human Rights Campaign (HRC) directly on the record. The HRC’s Corporate Equality Index is a voluntary survey that companies can participate in to have their gender-ideology workplace policies scored. To earn the CEI 100 designation, companies must cover sex-denying procedures for minor dependents under their employee health plans. Nike has scored 100 three years running. Inspire says Walmart told the group its plan doesn’t cover transgender surgeries for children. Walmart’s 2026 benefits book says gender reassignment surgery “is not considered medically necessary for individuals under the age of 18.” Inspire also says Charles Schwab told the group that it no longer covers such surgeries for children. Another conservative group, 1792 Exchange, wrote to 568 companies in June asking them to exclude transgender drugs and surgeries for children from employee health plans. Some companies have also decoupled from HRC. The full article can be found in Heartlander News.